Exhibit 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree that this statement on Schedule 13D with respect to the common stock of DUSA Pharmaceuticals, Inc. is, and any amendments hereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: November 19, 2012 |
| |
|
| |
|
| |
| CARACO ACQUISITION CORPORATION | |
|
| |
|
| |
| By: | /s/ Mukul Rathi |
| Name: | Mukul Rathi |
| Title: | President |
|
|
|
|
|
|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | |
|
|
|
|
|
|
| By: | /s/ Dilip S. Shanghvi |
| Name: | Dilip S. Shanghvi |
| Title: | Managing Director |
|
|
|
|
|
|
| SUN PHARMA GLOBAL, INC. | |
|
|
|
|
|
|
| By: | /s/ Harin Mehta |
| Name: | Harin Mehta |
| Title: | Managing Director |
|
|
|
|
|
|
| CARACO PHARMACEUTICAL LABORATORIES, LTD. | |
|
|
|
|
|
|
| By: | /s/ Mukul Rathi |
| Name: | Mukul Rathi |
| Title: | Interim Chief Financial Officer |
|
| |
|
| |
| DILIP S. SHANGHVI | |
|
| |
|
| |
| /s/ Dilip S. Shanghvi | |
| Dilip S. Shanghvi | |
